These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11260880)

  • 21. Preformulation investigation of the novel proton pump inhibitor lansoprazole.
    Kristl A; Vrecer F
    Drug Dev Ind Pharm; 2000 Jul; 26(7):781-3. PubMed ID: 10872099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
    Yenisehirli A; Onur R
    Eur J Pharmacol; 2005 Sep; 519(3):259-66. PubMed ID: 16125697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 24. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
    Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
    Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.
    Yurtsever AS; Pektas M; Ozkur M; Un I; Erenmemisoglu A; Buyukafsar K
    J Pharm Pharmacol; 2011 Oct; 63(10):1295-300. PubMed ID: 21899545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans.
    Liu NN; Köhler JR
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1145-7. PubMed ID: 26596946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lansoprazole: a proton pump inhibitor.
    Garnett WR
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
    Peddicord TE; Olsen KM; Collier DS
    Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.
    Sakai T; Aoyama N; Kita T; Sakaeda T; Nishiguchi K; Nishitora Y; Hohda T; Sirasaka D; Tamura T; Tanigawara Y; Kasuga M; Okumura K
    Pharm Res; 2001 Jun; 18(6):721-7. PubMed ID: 11474773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Lorentzon P; Bayati A; Lee H; Andersson K
    Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
    Nagaya H; Satoh H
    Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages.
    Diez-Orejas R; Feito MJ; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
    Colloids Surf B Biointerfaces; 2018 Nov; 171():250-259. PubMed ID: 30036792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
    Rizzo N; Padoin C; Palombo S; Scherrmann JM; Girre C
    Eur J Clin Pharmacol; 1996; 49(6):491-5. PubMed ID: 8706775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis.
    Nakamura M; Asada M; Atsuda K; Matsui H; Watanabe T; Higuchi K; Arakawa T; Hibi N; Tsuchimoto K
    Inflammopharmacology; 2005; 13(1-3):303-15. PubMed ID: 16259749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous lansoprazole: in erosive oesophagitis.
    Dando TM; Plosker GL
    Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode.
    Radi A
    J Pharm Biomed Anal; 2003 Apr; 31(5):1007-12. PubMed ID: 12684113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S
    Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
    Baldi F; Cappiello R; Cavoli C; Ghersi S; Torresan F; Roda E
    World J Gastroenterol; 2006 Jan; 12(1):82-8. PubMed ID: 16440422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
    Naseri E; Yenisehirli A
    Eur J Pharmacol; 2006 Feb; 531(1-3):226-31. PubMed ID: 16438963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.